Guderian, Carsten C.; Bican, Peter M.; Riar, Frederik J.; Sarbani, Chattopadhyay (2021). Innovation Management in Crisis: Patent Analytics as a Response to the Covid-19 Pandemic. R&D Management, 51(2), pp. 223-239. Wiley 10.1111/radm.12447
|
Text
R___D_Management_-_2020_-_Guderian_-_Innovation_management_in_crisis__patent_analytics_as_a_response_to_the_COVID_19.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (842kB) | Preview |
Crises like the COVID-19 pandemic affect firms’ innovation management and decision
making. On the downside, crises lead to detriments like budget constraints, to which firms
often respond by reducing their innovation activities. On the upside, crises are opportunities, where some firms exploiting changing market requirements and necessities excel. No
matter in which direction, decision makers must react quickly but often rely on ad-hoc
decisions or even gut feeling when drafting their crisis response strategies. Through a series
of distinct cases, we demonstrate that innovation management may fill this void through
patent analytics. Drawing on biochemical expertise, we particularly describe the functions
and effects of COVID-19. To counter downside detriments, firms may circumvent budget
constraints by discerning patents that can be (1) monetized, for example via sales or licensing deals, or (2) abandoned to achieve cost-savings, allowing firms to maintain their innovation activities. To realize upside opportunities, firms and governments may use patent
analytics to detect key biotechnology firms that are likely to successfully develop treatments
and vaccinations against pandemics like COVID-19. Promulgated U.S. interest in relocating
foreign firms to the United States is not without technological and commercial reasoning.
Herein, the insights of this study contribute to a better understanding of the use of patent
information, such as smart patent indicators, harmonized patent data, novel annuity fee
measures, and hand-collected datasets of COVID-19 and related antibodies’ patents to the
management of innovation in times of crisis.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
03 Faculty of Business, Economics and Social Sciences > Department of Business Management > Institute of Organization and Human Resource Management > Human Resource Management 03 Faculty of Business, Economics and Social Sciences > Department of Business Management > Institute of Organization and Human Resource Management |
UniBE Contributor: |
Riar, Frederik |
Subjects: |
300 Social sciences, sociology & anthropology 300 Social sciences, sociology & anthropology > 330 Economics 600 Technology > 650 Management & public relations |
ISSN: |
0033-6807 |
Publisher: |
Wiley |
Language: |
English |
Submitter: |
Frederik Johannes Riar |
Date Deposited: |
29 Mar 2022 16:52 |
Last Modified: |
05 Dec 2022 16:13 |
Publisher DOI: |
10.1111/radm.12447 |
BORIS DOI: |
10.48350/166946 |
URI: |
https://boris.unibe.ch/id/eprint/166946 |
Actions (login required)
 |
Edit item |